SOHM, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SHMN research report →
Companywww.sohm.com
SOHM, Inc. develops, manufactures, markets, and distributes generic and private label pharmaceutical products in the United States. It offers analgesics, antibiotics, anti-cold, and anti-inflammatory drugs, as well as over-the-counter, cosmeceuticals, and nutraceutical products.
- CEO
- Baron Night
- IPO
- 2010
- Employees
- 145
- HQ
- Corona, CA, US
Price Chart
Valuation
- Market Cap
- $1.73M
- P/E
- -6.29
- P/S
- 1.47
- P/B
- 0.82
- EV/EBITDA
- -8.63
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 74.53%
- Op Margin
- -42.84%
- Net Margin
- -42.96%
- ROE
- -46.81%
- ROIC
- -7.75%
Growth & Income
- Revenue
- $1.18M · 24.22%
- Net Income
- $-506,484 · 16.68%
- EPS
- $0.00 · 166.67%
- Op Income
- $-505,036
- FCF YoY
- 0.00%
Performance & Tape
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 0.77
- Avg Volume
- 762.50K
Get TickerSpark's AI analysis on SHMN
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our SHMN Coverage
We haven't published any research on SHMN yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate SHMN Report →